Atria Investments Inc reduced its holdings in shares of Morningstar, Inc. (NASDAQ:MORN - Free Report) by 38.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,529 shares of the business services provider's stock after selling 2,174 shares during the quarter. Atria Investments Inc's holdings in Morningstar were worth $1,126,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in MORN. M&G Plc boosted its stake in shares of Morningstar by 2.0% during the second quarter. M&G Plc now owns 173,105 shares of the business services provider's stock valued at $51,239,000 after acquiring an additional 3,322 shares during the last quarter. Tidal Investments LLC acquired a new stake in shares of Morningstar during the 1st quarter worth about $1,207,000. Harbor Capital Advisors Inc. boosted its position in Morningstar by 295.4% during the second quarter. Harbor Capital Advisors Inc. now owns 2,637 shares of the business services provider's stock worth $780,000 after acquiring an additional 1,970 shares during the last quarter. Assenagon Asset Management S.A. purchased a new stake in Morningstar in the 2nd quarter worth approximately $9,366,000. Finally, CANADA LIFE ASSURANCE Co raised its holdings in Morningstar by 12.7% in the 1st quarter. CANADA LIFE ASSURANCE Co now owns 17,696 shares of the business services provider's stock valued at $5,452,000 after acquiring an additional 1,997 shares during the last quarter. Institutional investors and hedge funds own 57.02% of the company's stock.
Analyst Ratings Changes
MORN has been the subject of a number of recent analyst reports. Redburn Atlantic downgraded Morningstar from a "buy" rating to a "neutral" rating and set a $340.00 price objective for the company. in a research report on Wednesday, October 9th. StockNews.com upgraded shares of Morningstar from a "hold" rating to a "buy" rating in a report on Friday. BMO Capital Markets reissued an "outperform" rating and set a $352.00 price objective on shares of Morningstar in a research note on Wednesday, August 28th. Finally, UBS Group assumed coverage on shares of Morningstar in a report on Tuesday, October 8th. They set a "buy" rating and a $390.00 target price on the stock. One investment analyst has rated the stock with a hold rating and three have given a buy rating to the company's stock. Based on data from MarketBeat.com, Morningstar presently has a consensus rating of "Moderate Buy" and an average price target of $360.67.
Get Our Latest Report on MORN
Insider Buying and Selling
In related news, Director William M. Lyons sold 750 shares of the stock in a transaction on Monday, September 30th. The stock was sold at an average price of $316.48, for a total transaction of $237,360.00. Following the completion of the sale, the director now directly owns 13,590 shares in the company, valued at approximately $4,300,963.20. This trade represents a 5.23 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Chairman Joseph D. Mansueto sold 3,838 shares of Morningstar stock in a transaction on Monday, August 19th. The shares were sold at an average price of $315.90, for a total value of $1,212,424.20. Following the sale, the chairman now directly owns 10,581,130 shares of the company's stock, valued at approximately $3,342,578,967. The trade was a 0.04 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 71,195 shares of company stock valued at $23,252,260. 39.90% of the stock is owned by corporate insiders.
Morningstar Stock Performance
Shares of NASDAQ:MORN traded down $5.42 on Friday, hitting $337.57. The company's stock had a trading volume of 128,763 shares, compared to its average volume of 155,994. The stock's 50-day moving average is $329.41 and its two-hundred day moving average is $311.52. The company has a market capitalization of $14.48 billion, a price-to-earnings ratio of 44.59 and a beta of 1.18. Morningstar, Inc. has a 12 month low of $264.79 and a 12 month high of $352.55. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.14 and a current ratio of 1.14.
Morningstar (NASDAQ:MORN - Get Free Report) last released its earnings results on Wednesday, October 23rd. The business services provider reported $2.00 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.01 by ($0.01). Morningstar had a return on equity of 23.28% and a net margin of 14.69%. The firm had revenue of $569.40 million for the quarter.
Morningstar Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Thursday, October 31st. Stockholders of record on Friday, October 4th were paid a dividend of $0.405 per share. This represents a $1.62 annualized dividend and a dividend yield of 0.48%. The ex-dividend date was Friday, October 4th. Morningstar's dividend payout ratio is presently 21.40%.
Morningstar Company Profile
(
Free Report)
Morningstar, Inc provides independent investment insights in the United States, Asia. Australia, Continental Europe, the United Kingdom, and internationally. The company operates in five segments: Morningstar Data and Analytics; PitchBook; Morningstar Wealth; Morningstar Credit; and Morningstar Retirement.
See Also
Before you consider Morningstar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Morningstar wasn't on the list.
While Morningstar currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.